Navigation Links
DNA OligoMix from LC Sciences

ProductsDNA OligoMix from LC Sciences
Company LC Sciences
Item DNA OligoMix
Price 
Description LC Sciences provides a unique new tool, OligoMix for low cost, high throughput DNA synthesis serving diverse needs in genomics, proteomics, synthetic biology, drug discovery, and microarray applications. OligoMix is a MIXTURE of a large number of DESIGNED synthetic DNA oligonucleotide sequences delivered in a single microtube. OligoMix is made from an innovative method of synthesis (1,2) and costs our customers 20 less per base than conventional synthesis.

OligoMix may contain any customer defined sequences (up to ~90 nts in length), OH, phosphate, or other types of 5 terminal groups, and OH or phosphate 3 terminal groups. Send us your sequences and in one-two weeks we deliver the OligoMix in pmol quantities ready for your applications such as hybridization, amplification, primer extension, and ligation.

We offer additional services for OligoMix: bioinformatics for sequence design, purification, sequence verification, preparation in duplex forms and restriction fragments, increasing product amount to nmol or more quantities, cloning and sequencing, and transcription into RNA OligoMix or individual RNA sequences. Visit our web site for more information about this product and the powerful genomic applications of OligoMix.

Economical
At less than 0.8 per base, DNA OligoMix contains thousands to millions of sequences and costs 20 less than conventional synthesis; savings is even more dramatic on long sequences.

Simple
Simply email your sequences in a text or Excel format and obtain synthesized sequences quickly. All sequences are delivered in one tube significantly increasing your experimental throughput. There is no need for robotic liquid handling or a large storage space.

Customizable
Based on conventional DMT nucleotide chemistry, our synthesis technology is very flexible and you may incorporate nucleotide modifications to suit your specific needs. Incorporation of nucleotide modifications substantially increases the number of applications of this product.

LC Sciences
LC Sciences is a genomics and proteomics company offering innovative and customizable products based on the Paraflo microfluidic technology. We offer unique products for construction of biomolecular libraries containing up to millions of different biomolecules of defined sequences. These products significantly reduce the cost and increase the speed of highly multiplexing genome-scale experiments such as exploration of small RNAs and designer gene/DNA library synthesis.

We additionally offer comprehensive microarray services for nucleic acid/protein profiling and functional analysis, biomarker-discovery, novel drug screening, and the custom development of diagnostic devices. Our microarray services offer standard and custom synthesized microarrays based on the Paraflo on-chip synthesis technology (1,2) which enables the high quality microarray synthesis and total customization of sequence content and incorporation of modifications.

(1) Tian, J., Gong, H., Sheng, N., Zhou, X., Gulari, E., Gao, X., and Church, G. (2004) Accurate multiplex gene synthesis from programmable DNA chips. Nature 432, 1050-1054.

(2) Zhou, X., Cai, S., Hong, A., Yu, P., Sheng, N., Srivannavit, O., Yong, Q., Muranjan, S., Rouillard, J. M., Xia, Y., Zhang, X., Xiang, Q., Ganesh, R., Zhu, Q., Makejko, A., Gulari, E., and Gao, X. (2004) Microfluidic picoarray synthesis of oligodeoxynucleotides and simultaneously assembling of multiple DNA sequences. Nucleic Acids Res. 32, 5409-5417.
Info LC SciencesLC Sciences
2575 W. Bellfort
Suite 270
Houston, TX 77054

Call LC Sciences to buy products (US and Canada only; other locations use numbers below)
USA Canada 1-713-574-7399
Customer Service: (713) 664-7087 or Toll Free: (888) 528-8818
Fax Number: (713) 664-8181
Web Site: http://www.lcsciences.com
NOTE: Price information is approximate list price and actual prices may vary.

Related biology products :

1. RNA OligoMix from LC Sciences
2. DNA/RNA Aptamer Microarray - Comprehensive Service from LC Sciences
3. Standard Protein Kinase Substrate (PKS) Peptide Microarray from LC Sciences
4. Protein Kinase Substrate (PKS) Peptide Microarray - Comprehensive Service from LC Sciences
5. Small Non-coding RNA Discovery Microarray - Comprehensive Service from LC Sciences
6. Custom 2-OMe RNA Aptamer Microarray from LC Sciences
7. Custom DNA Aptamer Microarray from LC Sciences
8. Epitope Peptide Microarray - Comprehensive Service from LC Sciences
9. Custom 2-F RNA Aptamer Microarray from LC Sciences
10. Custom Peptide Microarray - Comprehensive Service from LC Sciences
11. Standard DNA Aptamer Microarray from LC Sciences
... The TUNEL-based assay kit provides complete components ... convenient detection of DNA fragmentation in cultured ... an one-step labeling of apoptotic cells. ... of apoptosis in mammalian cells. MBLs ApoDIRECT ...
... imaging system allows imaging of fluorescent and ... 46cm at a pixel size as low ... suitable for protein electrophoresis in the proteomics ... Fuji s FLA-5100 includes four imaging solutions ...
... high speed and excellent temperature uniformity. Protocols ... Thermocycler can be run without any modifications. ... block for 48 or 96 wells. In ... in-situ applications are available. The High Precision ...
... The Sciclone inL10 Workstation from Caliper represents ... offering for the first time the ability ... automatically react to changing conditions. In ... in viscosity due to changes in temperature, ...
Biology Products:
(Date:2/12/2015)... Feb. 12, 2015   MedNet Solutions , ... clinical study management systems, has recently bolstered its ... distinguishing iMedNet as the ... (CROs) and healthcare consultants.  Building on the Program,s ... referrals and numerous co-marketing opportunities), MedNet,s new and ...
(Date:2/9/2015)... RICHARDSON, Texas , Feb. 9, 2015  Lintec ... novel fabrication methods for carbon nanotube (CNT) macrostructures, including ... Texas at Dallas (UTD). Leveraging the vast ... Tokyo, Japan , Lintec of America ... Richardson, TX , focusing on scaling ...
(Date:2/5/2015)... , Jan. 26, 2015 NXT-ID, Inc. (NASDAQ: ... a biometric authentication company focused on the growing mobile ... website ( http://www.nxt-id.com/ ) as part of its 2015 ... The Company launched its new consumer website for Wocketwallet.com ... , CEO of NXT-ID said, "Our new corporate website ...
Breaking Biology News(10 mins):MedNet Solutions Announces Key Enhancements To Its iMedNet Partner Program 2Lintec announces exclusive license to commercialize innovative carbon nanotube technology from the University of Texas at Dallas 2Lintec announces exclusive license to commercialize innovative carbon nanotube technology from the University of Texas at Dallas 3Lintec announces exclusive license to commercialize innovative carbon nanotube technology from the University of Texas at Dallas 4NXT-ID, Inc. Launches New Corporate Website As Part Of Ongoing 2015 Branding Initiatives For Wocket Smart Wallet 2NXT-ID, Inc. Launches New Corporate Website As Part Of Ongoing 2015 Branding Initiatives For Wocket Smart Wallet 3
... Dalhousie University in Nova Scotia have identified a key ... growth if their findings are confirmed. In ... journal of the American Association for Cancer Research, lead ... Biochemistry and Molecular Biology and Pathology, and Canada Research ...
... it,s on to proteins, a much more daunting task. There ... molecules in our bodies. Many of these hold keys to ... Northwestern University chemical biologist Neil Kelleher has developed a new ... molecules quickly. Many have been skeptical that such an approach, ...
... major public symposium at Boston College will bring together four ... contributions of the physical and social sciences to a contemporary ... Liberal Arts University Why It Matters to Us All, ... the Liberal Arts, takes place today at the University,s main ...
Cached Biology News:Key driver of metastasis identified 2So many proteins, so much promise 2So many proteins, so much promise 3Science in the liberal arts university 2
(Date:3/4/2015)... , March 4, 2015 PDL BioPharma, Inc. (PDL) ... conversion rate for the: , 3.75% Convertible Senior ... shares of common stock per $1,000 principal amount or approximately ... conversion rate for the note is adjusted in connection with ... March 12, 2015, to all stockholders who own shares of PDL ...
(Date:3/4/2015)... , Mar. 04, 2015 Research and ... the addition of Jain PharmaBiotech,s new report ... their offering. This report follows ... characteristic that can be objectively measured and evaluated ... processes as well as pharmacological responses to a ...
(Date:3/4/2015)... , March 4, 2015 AcelRx Pharmaceuticals, ... pharmaceutical company focused on the development and commercialization ... and breakthrough pain, today announced that it will ... after market close on Monday, March 9th, 2015. ... at 4:30 p.m. Eastern Time (1:30 p.m. Pacific ...
(Date:3/4/2015)... PARIS , March 4, 2015 ... Hopitaux de Paris en ... «   SARAH   », qui compare   ... l,yttrium-90 avec le   sorafénib dans le carcinome ... atteints d,un cancer du foie avancé   ; ...
Breaking Biology Technology:PDL BioPharma Announces Conversion Rate Adjustment for Convertible Note 2Global Biomarkers Report 2014-2024 - Technologies, Markets and Companies 2Global Biomarkers Report 2014-2024 - Technologies, Markets and Companies 3AcelRx Pharmaceuticals to Hold Annual 2014 Financial Results Conference Call and Webcast on Monday, March 9th, 2015 2AcelRx Pharmaceuticals to Hold Annual 2014 Financial Results Conference Call and Webcast on Monday, March 9th, 2015 3Traitement du cancer primitif du foie : Recrutement terminé pour l'étude SARAH et résultats attendus fin 2016 2Traitement du cancer primitif du foie : Recrutement terminé pour l'étude SARAH et résultats attendus fin 2016 3Traitement du cancer primitif du foie : Recrutement terminé pour l'étude SARAH et résultats attendus fin 2016 4Traitement du cancer primitif du foie : Recrutement terminé pour l'étude SARAH et résultats attendus fin 2016 5Traitement du cancer primitif du foie : Recrutement terminé pour l'étude SARAH et résultats attendus fin 2016 6